1 big risk to UK shares in 2021 and how I’d invest for great returns anyway

2021 has started on a promising note, but it’s still fraught with risk. Manika Premsingh would buy these UK shares to still make good gains now.  

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

While going over updates for FTSE 100 and FTSE 250 shares earlier today, I found a curious trend. These UK shares are some of the biggest gainers. But their updates aren’t great.

In fact, some of them are still quite weak. I’m talking about stocks like luxury giant Burberry, publisher Pearson, and retailer WH Smith

So why are their prices rising? 

The big risk for UK shares

I think the combination of growing investor confidence and their changed assessment of company performance is the reason. So, the fact that these companies’ revenues are down, but less so than in their previous updates, is seen as positive. 

And there’s no doubt that progress is being made. 

But I think it’s important to remember that we are still living in a pandemic and it will be some time before we can truly claim victory over it. Until such time, there is still the risk of Covid-19 spreading, especially with new variants around. 

The longer the pandemic drags on, the worse it will be for business, making many companies and share prices increasingly vulnerable. 

How I’d buy UK shares now

Does that mean we should refrain from buying the affected UK shares?

I think there’s still much value to many of these stocks and they aren’t going under in a hurry. So the short answer is, no. At the same time, it’s important to keep in mind that these stocks aren’t exactly financially strong right now either. 

I’d buy some of them — in fact, I already have. 

Safer growth options

But I’d also hold shares with a high likelihood of growth and less risk. This will ensure that at least part of my portfolio is firmly on the growth path, even if the rest might struggle because of any untoward event. 

Some of the shares that did well during 2020, will continue to do this year, in my view. And there’s plenty of choice. 

FTSE 100 healthcare companies like AstraZeneca and Hikma Pharmaceuticals are examples. Support products and services providers like hygienist Rentokil Initial and face-mask and gloves distributor Bunzl are others. 

Ensuring some passive income

I’d also ensure that there are income-generating UK shares in my portfolio. This will ensure passive income (as companies increasingly start paying dividends) at the very least, even if the overall market is indifferent. 

The catch though, is this. I want to buy UK shares with relatively stable dividends. The large-scale disruption last year led to dwindling in dividends across the board. Some companies were exceptions however, and I’d consider them as potential income investments. 

The FTSE 100 industrial metals miner Rio Tinto is an example of a stock that not just continued to pay dividends, it also paid an interim dividend. With a yield close to 5%, it’s definitely one to consider. National Grid, with an even better yield of 5.6%, is another one, as are other FTSE 100 utilities

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Manika Premsingh owns shares of AstraZeneca and Rentokil Initial. The Motley Fool UK has recommended Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »